FDA 21 CFR Part 11 - Electronic Records; Electronic Signatures is issued by United States Food and Drug Administration (FDA) and applies most commonly in United States, Global. This page covers who typically pursues it, what drives the decision, and when it's worth the investment.
Who FDA 21 CFR Part 11 Applies To
FDA 21 CFR Part 11 is most relevant to:
- Enterprise
- Saas
Industries That Pursue FDA 21 CFR Part 11
Teams working in the following sectors regularly engage with FDA 21 CFR Part 11:
- Pharmaceutical
- Medical Devices
- Biotechnology
- Healthcare
Common Drivers
Organizations typically pursue FDA 21 CFR Part 11 for one or more of:
- Customer or enterprise procurement: prospects or existing customers require it as part of security review and vendor onboarding.
- Regulatory obligation: FDA 21 CFR Part 11 audits are formally required and gated by regulators or auditors.
- Risk reduction: the control framework surfaces real gaps — access management, change control, incident response — that would eventually bite without structure.
- Market signal: many buyers now treat the framework as a trust shortcut; achieving it accelerates sales cycles.
Where It Applies
FDA 21 CFR Part 11 is recognised in United States, Global. If you sell outside those regions, confirm whether buyers will accept FDA 21 CFR Part 11 or whether a locally-recognised alternative is required.
Alternatives and Adjacent Frameworks
If FDA 21 CFR Part 11isn't the right fit, buyers in the same space typically also accept:
Decision Checklist
- Is a customer or regulator asking for it in writing?
- Will the audit output be used repeatedly across prospects, or just once?
- Do you have the budget and six-month calendar required to see the process through?
- Could an adjacent framework (HIPAA or ISO 27001) satisfy the same ask more cheaply?
For a full step-by-step walkthrough, see the FDA 21 CFR Part 11 certification process page. For cost breakdowns, see the cheapest path to FDA 21 CFR Part 11.